mofezolac has been researched along with Blood Clot in 1 studies
mofezolac: Cyclooxygenase 1 inhibitor; structure in first source; RN from Toxlit
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perrone, MG | 1 |
| Miciaccia, M | 1 |
| Vitale, P | 1 |
| Ferorelli, S | 1 |
| Araújo, CDCB | 1 |
| de Almeida, GS | 1 |
| Souza Domingos, TF | 1 |
| da Silva, LCRP | 1 |
| de Pádula, M | 1 |
| Cabral, LM | 1 |
| Sathler, PC | 1 |
| Bonaccorso, C | 1 |
| Fortuna, CG | 1 |
| Scilimati, A | 1 |
1 other study available for mofezolac and Blood Clot
| Article | Year |
|---|---|
An attempt to chemically state the cross-talk between monomers of COX homodimers by double/hybrid inhibitors mofezolac-spacer-mofezolac and mofezolac-spacer-arachidonic acid.
Topics: Algorithms; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Blood Coagulation; C | 2021 |